Literature DB >> 3335631

Reductions of erythrocyte membrane viscoelastic coefficients reflect spectrin deficiencies in hereditary spherocytosis.

R E Waugh1, P Agre.   

Abstract

Hereditary spherocytosis is a common hemolytic anemia associated with deficiencies in spectrin, the principal structural protein of the erythrocyte membrane-skeleton. We have examined 20 different individuals from 10 spherocytosis kindreds and 2 elliptocytosis kindreds to determine the effects of different levels of spectrin deficiency on the viscoelastic properties of the erythrocyte membrane. Micropipettes were used to perform single-cell micromechanical measurements of approximately 1,000 individual cells to determine the membrane elastic shear modulus, the apparent membrane bending stiffness, and whole cell recovery time constant for the different cell populations. The membrane viscosity was calculated by the product of the shear modulus and the recovery time constant. Results show correlation between the fractional reduction in shear modulus and the fractional reduction in spectrin content (determined by spectrin radioimmunoassay) and spectrin density (determined by the ratios of spectrin to band 3 on electrophoresis gels) suggesting that membrane shear elasticity is directly proportional to the surface density of spectrin on the membrane (P less than 0.001). The apparent membrane bending stiffness is also reduced in proportion to the density of spectrin (P less than 0.001). The membrane viscosity is reduced relative to control (P less than 0.001), but the nature of the relationship between spectrin density and membrane viscosity is less clearly defined. These studies document striking relationships between partial deficiencies of erythrocyte spectrin and specific viscoelastic properties of the mutant membranes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335631      PMCID: PMC442484          DOI: 10.1172/JCI113284

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Herediatary spherocytosis. A review.

Authors:  R I Weed
Journal:  Arch Intern Med       Date:  1975-10

2.  Thermoelasticity of red blood cell membrane.

Authors:  R Waugh; E A Evans
Journal:  Biophys J       Date:  1979-04       Impact factor: 4.033

3.  Effects of inherited membrane abnormalities on the viscoelastic properties of erythrocyte membrane.

Authors:  R E Waugh
Journal:  Biophys J       Date:  1987-03       Impact factor: 4.033

4.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

5.  Quantification of Coomassie Blue stained proteins in polyacrylamide gels based on analyses of eluted dye.

Authors:  C Fenner; R R Traut; D T Mason; J Wikman-Coffelt
Journal:  Anal Biochem       Date:  1975-02       Impact factor: 3.365

6.  Bending elastic modulus of red blood cell membrane derived from buckling instability in micropipet aspiration tests.

Authors:  E A Evans
Journal:  Biophys J       Date:  1983-07       Impact factor: 4.033

7.  Erythrocyte membrane elasticity during in vivo ageing.

Authors:  G B Nash; S J Wyard
Journal:  Biochim Biophys Acta       Date:  1981-05-06

8.  Theoretical and experimental studies on viscoelastic properties of erythrocyte membrane.

Authors:  S Chien; K L Sung; R Skalak; S Usami; A Tözeren
Journal:  Biophys J       Date:  1978-11       Impact factor: 4.033

9.  Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis.

Authors:  P Agre; A Asimos; J F Casella; C McMillan
Journal:  N Engl J Med       Date:  1986-12-18       Impact factor: 91.245

10.  Partial deficiency of erythrocyte spectrin in hereditary spherocytosis.

Authors:  P Agre; J F Casella; W H Zinkham; C McMillan; V Bennett
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

View more
  41 in total

1.  Elasticity of the red cell membrane and its relation to hemolytic disorders: an optical tweezers study.

Authors:  J Sleep; D Wilson; R Simmons; W Gratzer
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Actin protofilament orientation at the erythrocyte membrane.

Authors:  C Picart; D E Discher
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

3.  Direct measures of large, anisotropic strains in deformation of the erythrocyte cytoskeleton.

Authors:  J C Lee; D T Wong; D E Discher
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

4.  Actin protofilament orientation in deformation of the erythrocyte membrane skeleton.

Authors:  C Picart; P Dalhaimer; D E Discher
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

5.  Deformation-enhanced fluctuations in the red cell skeleton with theoretical relations to elasticity, connectivity, and spectrin unfolding.

Authors:  J C Lee; D E Discher
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

6.  Bioelectrorheological model of the cell. 3. Viscoelastic shear deformation of the membrane.

Authors:  J Poznański; P Pawłowski; M Fikus
Journal:  Biophys J       Date:  1992-03       Impact factor: 4.033

7.  Conformation and elasticity of the isolated red blood cell membrane skeleton.

Authors:  K Svoboda; C F Schmidt; D Branton; S M Block
Journal:  Biophys J       Date:  1992-09       Impact factor: 4.033

8.  Lateral mobility of integral proteins in red blood cell tethers.

Authors:  D A Berk; R M Hochmuth
Journal:  Biophys J       Date:  1992-01       Impact factor: 4.033

Review 9.  Role of band 3 in the erythrocyte membrane structural changes under thermal fluctuations -multi scale modeling considerations.

Authors:  Ivana Pajic-Lijakovic
Journal:  J Bioenerg Biomembr       Date:  2015-11-11       Impact factor: 2.945

10.  Spectrin/band 3 ratio as diagnostic tool in hereditary spherocytosis.

Authors:  S Cutillo; L Pinto; B Nobili; E Miraglia del Giudice; A Iolascon
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.